USPTO serial 79452592
ISODDE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GAYNOR, BARBARA ANNE
- Law office
- TMO LAW OFFICE 115
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ISODDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Weighing apparatus and instruments; surveying apparatus and instruments; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; medical laboratory research instruments for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; medical laboratory research instruments for DNA analysis; scientific laboratory research instruments for DNA analysis; scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of protein, protein structures, molecules, molecule structures, and molecule interactions for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable audio and video recordings featuring information relating to protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of data and information; downloadable computer software for creating searchable databases of information and data; blank digital storage media; blank digital storage media, machine-readable; computers and computer peripheral devices; downloadable computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer programs for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; downloadable computer software for creating, analyzing, and running quantum algorithms; recorded computer programs using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development. | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development, and industrial analysis thereof; structural and functional analysis of genomes; design and development of computer hardware and software; software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI); research in the field of artificial intelligence (AI) technology; research, design and development of software using artificial intelligence; research and development of advanced learning technologies and teaching methods; design and development of artificial intelligence (AI) software; research and development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning; technological research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online non-downloadable computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; platform as a service (PAAS) featuring computer software platforms for artificial intelligence, machine learning, deep learning, and reinforcement learning; design and development of computer software; testing of computer hardware; testing of computer software; development and establishment of testing specifications and procedures in the field of computing methods, algorithms, computer software, and computer hardware; scientific research; pharmaceutical research services; medical research; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; pharmaceutical research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; providing scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; medical and scientific research information in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the field of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific and technological services, namely, scientific research, analysis, and testing in the field of organic compounds; biological research and analysis; biochemical research and analysis; drug discovery services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 8, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 1, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |